Literature DB >> 35860711

Report of a Patient With Anti-Jo-1 Syndrome With Loss of Consciousness.

Chun Chen1, Yu-Jang Su1,2,3,4, Chiong-Hee Wong1.   

Abstract

A 51-year-old febrile woman presented to the emergency department because of loss of consciousness while worshipping at a temple. She experienced muscle weakness and blurred vision before fainting. She also felt pain in her left shoulder and suffered from dry cough and shortness of breath during the previous week. The chest radiograph (CXR) showed bilateral reticular infiltration, indicating interstitial lung disease (ILD), and chest computed tomography revealed reticular, nodular, and reticulonodular patterns of infiltration that were compatible with ILD. Blood tests showed a creatinine kinase level of 3,307 IU/L and an Anti-Jo-1 autoantibody level of 586 AU/mL. It was found via right thigh biopsy results 8 days later that she had polymyositis with perivascular inflammation and degenerative muscle fiber change. Pulse therapy with methylprednisolone (1 gm/day for 3 days) was administered. After 4 days, she felt better and was discharged. Around 25.0%-34.1% of myositis patients have anti-Jo-1 autoantibodies, and ILD was noted in 65%-68% of anti-Jo-1-positive patients. A ground glass pattern may be observed in the CXRs of anti-Jo-1 ILD patients, and some articles described multiple pulmonary nodules mimicking lung metastasis or concomitant with pleural effusion. The conditions of approximately 42%-66% of ILD patients are controlled or are not worsened after treatment with corticosteroid and immunosuppressive drug treatment. However, some rapidly progressive cases are not sensitive to corticosteroid therapy alone.

Entities:  

Keywords:  anti-Jo-1 autoantibody ; interstitial lung disease ; polymyositis

Year:  2022        PMID: 35860711      PMCID: PMC9283115          DOI: 10.6705/j.jacme.202206_12(2).0004

Source DB:  PubMed          Journal:  J Acute Med        ISSN: 2211-5587


  14 in total

Review 1.  Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.

Authors:  C Marguerie; C C Bunn; H L Beynon; R M Bernstein; J M Hughes; A K So; M J Walport
Journal:  Q J Med       Date:  1990-10

2.  Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.

Authors:  R M Bernstein; S H Morgan; J Chapman; C C Bunn; M B Mathews; M Turner-Warwick; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-21

3.  Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.

Authors:  Pawel Mielnik; Ewa Wiesik-Szewczyk; Marzena Olesinska; Hanna Chwalinska-Sadowska; Jakub Zabek
Journal:  Autoimmunity       Date:  2006-05       Impact factor: 2.815

Review 4.  Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations.

Authors:  Gerald J D Hengstman; Baziel G M van Engelen; Walther J van Venrooij
Journal:  Curr Opin Rheumatol       Date:  2004-11       Impact factor: 5.006

5.  Rapidly progressive interstitial lung disease in a dermatomyositis patient with high levels of creatine phosphokinase, severe muscle symptoms and positive anti-Jo-1 antibody.

Authors:  Kosuke Kashiwabara; Kosuke Ota
Journal:  Intern Med       Date:  2002-07       Impact factor: 1.271

6.  Interstitial lung disease in dermatomyositis: clinicopathological study.

Authors:  H Takizawa; J Shiga; Y Moroi; S Miyachi; M Nishiwaki; T Miyamoto
Journal:  J Rheumatol       Date:  1987-02       Impact factor: 4.666

7.  Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis.

Authors:  M Fathi; M Dastmalchi; E Rasmussen; I E Lundberg; G Tornling
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

8.  Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.

Authors:  Cecilie Dobloug; Torhild Garen; Helle Bitter; Johan Stjärne; Guri Stenseth; Lars Grøvle; Marthe Sem; Jan Tore Gran; Øyvind Molberg
Journal:  Ann Rheum Dis       Date:  2014-04-02       Impact factor: 19.103

Review 9.  Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Ira N Targoff
Journal:  Rheum Dis Clin North Am       Date:  2002-11       Impact factor: 2.670

10.  Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.

Authors:  Minna Jiang; Xin Dong; Yi Zheng
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.